Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus

Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus

Ebola virus (EBOV) is a zoonotic pathogen that poses a significant threat to public health, causing sporadic yet devastating outbreaks that have the potential to spread worldwide, as demonstrated during the 2013−2016 West African outbreak. Mouse models of infection are important tools for...

Full description

Bibliographic Details
Main Authors:	Mable Chan, Anders Leung, Bryan D. Griffin, Robert Vendramelli, Nikesh Tailor, Kevin Tierney, Jonathan Audet, Darwyn Kobasa
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Viruses
Subjects:	ebola virus makona mayinga mouse-adapted animal model mice reverse genetics pathogenesis vp24
Online Access:	https://www.mdpi.com/1999-4915/11/11/987

Similar Items

Investigating the Cellular Transcriptomic Response Induced by the Makona Variant of Ebola Virus in Differentiated THP-1 Cells
by: Andrew Bosworth, et al.
Published: (2019-11-01)

Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain
by: Andrea Marzi, et al.
Published: (2015-10-01)

Evaluating Environmental Persistence and Disinfection of the Ebola Virus Makona Variant
by: Bradley W. M. Cook, et al.
Published: (2015-04-01)

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
by: Andrea R. Menicucci, et al.
Published: (2017-10-01)

Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates
by: Ronald B. Reisler, et al.
Published: (2017-08-01)

Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity
by: Lin Zhu, et al.
Published: (2024-01-01)

The Minor Matrix Protein VP24 from Ebola Virus Lacks Direct Lipid-Binding Properties
by: Yuan Su, et al.
Published: (2020-08-01)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
by: Angela R. Harrison, et al.
Published: (2021-08-01)

Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes
by: Todd A. Cutts, et al.
Published: (2020-06-01)

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
by: Supriya Ravichandran, et al.
Published: (2022-08-01)

Extracellular vesicle storm during the course of Ebola virus infection in primates
by: Andrea Vucetic, et al.
Published: (2023-11-01)

H7N9 Influenza Virus Containing a Polybasic HA Cleavage Site Requires Minimal Host Adaptation to Obtain a Highly Pathogenic Disease Phenotype in Mice
by: Mable Chan, et al.
Published: (2020-01-01)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
by: Michelle L. Pleet, et al.
Published: (2016-11-01)

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription
by: Yuki Takamatsu, et al.
Published: (2020-02-01)

Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia
by: Jeffrey R. Kugelman, et al.
Published: (2015-07-01)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
by: Michelle L. Pleet, et al.
Published: (2018-04-01)

Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
by: Louis K. S. Darko, et al.
Published: (2021-11-01)

Pulmonary Involvement during the Ebola Virus Disease
by: Eleonora Lalle, et al.
Published: (2019-08-01)

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
by: Emmanuel Broni, et al.
Published: (2023-03-01)

Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus
by: Todd A. Cutts, et al.
Published: (2021-08-01)

Molecular docking study of anti-viral FDA-approved drugs as novel entry and replication Ebola viral inhibitors
by: Saghi Sepehri, et al.
Published: (2019-04-01)

Updates in diagnosis and management of Ebola hemorrhagic fever
by: Salah Mohamed El Sayed, et al.
Published: (2016-01-01)

Novel Antiviral Molecules against Ebola Virus Infection
by: Mila Collados Rodríguez, et al.
Published: (2023-09-01)

Evaluation of fendiline treatment in VP40 system with nucleation-elongation process: a computational model of Ebola virus matrix protein assembly
by: Xiao Liu, et al.
Published: (2024-04-01)

Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014
by: Jens H. Kuhn, et al.
Published: (2014-11-01)

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
by: Michelle L. Pleet, et al.
Published: (2019-05-01)

Evasion of the Interferon-Mediated Antiviral Response by Filoviruses
by: Washington B. Cárdenas
Published: (2010-01-01)

Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling
by: Elisa Fanunza, et al.
Published: (2018-02-01)

Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription
by: Jingliang Chen, et al.
Published: (2019-01-01)

The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
by: Wenjun Zhu, et al.
Published: (2019-10-01)

Adipose Tissues from Human and Bat-Derived Cell Lines Support Ebola Virus Infection
by: Lauren Garnett, et al.
Published: (2023-08-01)

Ébola (Enfermedad por el Virus del Ébola
by: Cristina Fernández Barrantes
Published: (2014-11-01)

Host and Viral Proteins Modulating Ebola and Marburg Virus Egress
by: Tamsin B. Gordon, et al.
Published: (2019-01-01)

Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form
by: Sara Landeras-Bueno, et al.
Published: (2021-04-01)

Ebola virus disease and children
by: V.S. Andrоukh, et al.
Published: (2018-11-01)

The Boundaries of Treating Ebola
by: Dallas Ducar
Published: (2014-08-01)

Ethicizing the Ebola Epidemic
by: Louisa Howard
Published: (2014-10-01)

Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain
by: Nodoka Kasajima, et al.
Published: (2021-11-01)

A Loop Region in the N-Terminal Domain of Ebola Virus VP40 Is Important in Viral Assembly, Budding, and Egress
by: Emmanuel Adu-Gyamfi, et al.
Published: (2014-10-01)

Ebola: Working Through Fear
by: Brenda Fitzgerald
Published: (2015-04-01)